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Objectives: Candida glabrata is one of the most common causes of Candida
bloodstream infections worldwide. Some isolates of C glabrata may be inter-
mediately resistant to azoles, with some strains developing resistance during
therapy or prophylaxis with fluconazole. In this study, we used a proteomic
approach to identify differentially expressed proteins between fluconazole-
resistant and -susceptible strains.
Methods: Membrane and cellular proteins were extracted from fluconazole-
susceptible and fluconazole-resistant C glabrata strains. Differentially expressed
proteins were compared using two-dimensional sodium dodecyl sulfate poly-
acrylamide gel electrophoresis. Proteins with >1.5-fold difference in expression
were identified by liquid chromatography tandemmass spectrometry (LC-MS/MS).
Results: A total of 65 proteins were differentially expressed in the cellular and
membrane fractions. Among the 39 cellular proteins, 11 were upregulated and 28
were downregulated in fluconazole-resistant strains in comparison with
fluconazole-susceptible strains. In the membrane fraction, a total of 26 proteins
were found, of which 19 were upregulated and seven were downregulated. A
total of 31 proteins were identified by LC-MS/MS that are involved in glycolysis,
carbohydrate transport, energy transfer, and other metabolic pathways. Heat
shock proteins were identified in various spots.
Conclusion: Heat shock and stress response proteins were upregulated in the
membrane fraction of the fluconazole-resistant C glabrata strain. Compared with
susceptible strains, fluconazole-resistant strains showed increased expression of
membrane proteins and decreased expression of cellular proteins.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
) which permits unrestricted non-commercial use, distribution, and reproduction in any
operly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
Fluconazole-resistant Candida glabrata 751. Introduction
The incidence of life-threatening fungal infections
has increased steadily over the most recent decade
[1,2]. In the most recent years, there has been
increased interest in the opportunistic pathogen,
Candida, which is responsible for the majority of
fungal infections. Indeed, the increase in Candida
blood infections among hospitalized patients and the
rising incidence of infections caused by non-albicans
Candida species, including C glabrata, C tropicalis,
and C parapsilosis, have been noted [3]. In particular,
C glabrata has emerged as a major cause of mucosal
and invasive fungal infection in the United States,
second only to C albicans [4]. The rise in the number
of C glabrata systemic infections deserves a great deal
of attention due to the high mortality rate associated
with C glabrata fungemia [5]. Because the frequency
of fungal infections is increasing, the need for anti-
fungal agents has correspondingly increased, but anti-
fungal agents are restricted to a few compounds. In
particular, fluconazole is a highly effective wide-
spectrum antifungal agent that is widely prescribed
for the treatment of superficial and systemic candidi-
asis because it can be orally administered. However,
the widespread and prolonged use of azoles in recent
years has led to the rapid development of drug resis-
tance in Candida species [6,7]. C glabrata infections
are difficult to treat and are often resistant to many
azole antifungal agents, especially fluconazole [8,9].
Fluconazole has limited activity against C glabrata
because C glabrata has an intrinsically low suscepti-
bility to azole antifungal agents. Furthermore, acquired
azole resistance has recently been reported in oral
isolates of C glabrata from hematopoietic stem cell
transplant recipients and patients who have received
radiation for the treatment of head and neck cancer
[9,10]. The mechanisms underlying C albicans resis-
tance to azole antifungal agents have been well eluci-
dated. Nonetheless, the molecular basis for the
intrinsically low susceptibility of C glabrata remains
unclear. Several mechanisms of acquired resistance to
azole antifungal agents have been proposed, including
the upregulation of the genes that encode the ATP-
binding cassette (ABC) transporters (CDR1 and CDR2)
[11] and the target of azole antifungal agents, lano-
sterol 14-a-demethylase (ERG11) [12]. Recently,
a proteomic analysis of multiple matched sets of azole-
susceptible and azole-resistant Candida isolates was
undertaken in order to understand the mechanisms
underlying azole antifungal resistance. In this study, we
investigated changes in the expression levels of cellular
and membrane proteins between fluconazole-resistant
and -susceptible C glabrata strains. Here, we report
several proteins that were found to be associated with
fluconazole resistance.2. Materials and Methods
2.1. C glabrata strains and growth conditions
We previously reported the results of an antifungal
susceptibility test [13]. Based on those results, we
selected four C glabrata strains according to their flu-
conazole susceptibility for a comparative proteomic
study. To minimize variation between strains, two
strains of each type (fluconazole-susceptible and
fluconazole-resistant) were used. All strains were stored
at -80C. Prior to testing, each strain was subcultured
twice on Sabouraud dextrose agar (Difco, Co., USA) to
ensure viability and purity. For the proteomic analysis,
an aliquot of the glycerol stock of each strain was
diluted in YPD broth (1% yeast extract, 2% peptone, and
1% dextrose) and cultured overnight at 30C in
a shaking incubator. The cultures were diluted to an
optical density 0.2 at OD600 in 0.5 L of fresh YPD broth
and grown as before to the logarithmic phase and an
equivalent optical density.
2.2. Cellular and membrane protein extraction
C glabrata was cultured in YPD broth at 30C to the
late exponential phase of growth. Cells were harvested,
washed with distilled water, and resuspended in
homogenizing buffer (50 mM Tris-HCl, 2 mM EDTA,
and 1 mM phenylmethylsulfonyl fluoride; pH 7.5). The
cells were then disrupted using glass beads. Cell debris
and any unbroken cells were removed by centrifugation
at 5000 g at 4C for 10 minutes. The supernatants
were pooled, desalted, concentrated, and analyzed for
cellular proteins. A crude membrane fraction was iso-
lated from the cell-free supernatant (after cell disrup-
tion) by centrifugation at 30,000 g at 4C for 30
minutes. The pellets were washed in GTE buffer
(10 mM Tris-HCl, 0.5 mM EDTA, 20% [v/v] glycerol;
pH 7.0), resuspended in GTE buffer, and stored at
-80C. The protein concentration was determined using
a micro-Bradford assay in the protein assay kit II (Bio-
Rad, Hercules, CA, USA).
2.3. Two-dimensional gel electrophoresis
analysis
For the two-dimensional (2D) gel electrophoresis
analysis, pH 3e10 immobilized pH gradient (IPG) strips
(Amersham Biosciences, Amersham Co., USA) were
rehydrated in a swelling buffer containing 7 M urea, 2 M
thiourea, 0.4% (w/v) DTT, and 4% (w/v) CHAPS. The
protein lysates (500 mg) were cup-loaded into the rehy-
drated IPG strips using a Multiphor II apparatus (Amer-
sham Biosciences) at 57 kVh. Two-dimensional gel
separation was performed on 8e16% (v/v) linear gradient
sodium dodecyl sulfate (SDS) polyacrylamide gels. Then,
the gels were fixed, stained, destained, and imaged using
a GS-710 imaging calibrated densitometer (Bio-Rad).
Protein spot detection and 2D pattern matching were
76 J.I. Yoo, et alcarried out using ImageMasterTM 2D Platinum software
(Amersham Biosciences). To compare the protein spot
densities between the control and treated samples, > 20
spots throughout all of the gels were correspondingly
landmarked and normalized. To ensure the reproduc-
ibility of the 2D gel electrophoresis experiments, each
sample was analyzed in duplicate.
2.4. In-gel protein digestion
Protein bands of interest were excised and digested
in-gel with sequencing-grade, modified trypsin (Prom-
ega, Madison, WI, USA) as previously described [14].
In brief, each protein spot was excised from the gel,
placed in a polypropylene (Eppendorf) tube, and washed
4e5 times (until the gel was clear) using 150 mL of a 1:1
mixture of acetonitrile:25 mM ammonium bicarbonate
at pH 7.8. The gel slices were dried and rehydrated. The
tryptic peptides that remained in the gel matrix were
extracted for 40 minutes at 30C using 20 mL of 50% (v/
v) aqueous acetonitrile containing 0.1% (v/v) formic
acid. The combination supernatants were evaporated
and dissolved in 8 mL of 5% (v/v) aqueous acetonitrile
solution containing 0.1% (v/v) formic acid for mass
spectrometry analysis.
2.5. Identification of proteins by liquid
chromatography tandem mass
spectrometry
The resulting tryptic peptides were separated and
analyzed using capillary reversed-phase high-perfor-
mance liquid chromatography (HPLC) that was directly
coupled to a Thermo Finnigan LCQ ion trap mass
spectrometer (LC-MS/MS) [15]. The individual spectra
from MS/MS were processed using TurboSEQUEST
software (Thermo Quest, San Jose, CA, USA). The
generated peak list files were used to query either the
MSDB database or NCBI using the MASCOT programFigure 1. Cellular and membrane protein spots of C glabrata
phoresis. Spots representing differentially expressed proteins were
trometry (LC-MS/MS) peptide mass fingerprinting. (A) Cellular
proteins spots of fluconazole-resistant strains. (C) Membrane pro
protein spots of fluconazole-resistant strains.(http://www.matrixscience.com, matrix science Ltd.).
Modifications to methionine and cysteine, peptide mass
tolerance at 2 Da, MS/MS ion mass tolerance at 0.8 Da,
allowance of missed cleavage at 2, and charge states
(þ1, þ2, and þ3) were taken into account. Only
significant hits as defined by the MASCOT probability
analysis were initially considered.3. Results
3.1. Analysis of the 2D gel spots
Among the clinically isolated C glabrata strains, the C
glabrata D-31 and D-33 strains were identified as
fluconazole-susceptible strains and theC. glabrataD-116
and D-149 strains were identified as fluconazole-resistant
strains. Using 2D gel electrophoresis, the differential
expression of proteins between the fluconazole-
susceptible and -resistant strains was investigated
(Figure 1). Regarding themembrane proteins, a total of 26
protein spotswere found to be differentially expressed (by
1.5-fold) in fluconazole-resistant C glabrata strains in
comparison with fluconazole-susceptible strains. Among
these proteins, 19 proteins were upregulated and 7
proteins were downregulated in the fluconazole-resistant
strains. As for the cellular proteins, a total of 39 protein
spots were found to be differentially expressed in
fluconazole-resistant versus fluconazole-susceptible
strains. Among these 39 proteins, 11 were upregulated
and 28 were downregulated. The protein spots were
evenly spread throughout the pH 3e10 IPG gel.
3.2. Identification of differentially expressed
proteins
Using LC-MS/MS, a total of 31 proteins were identi-
fied in the cellular and membrane protein fractions. In the
membrane protein fraction, the expression of stressstrains that were resolved using two-dimensional gel electro-
later identified by liquid chromatography-tandem mass spec-
protein spots of fluconazole-susceptible strains. (B) Cellular
tein spots of fluconazole-susceptible strains. (D) Membrane
Table 1. Differentially expressed membrane proteins, as identified by LC-MS/MS between of fluconazole-susceptible and








151 Ugp1 55.916 6.98 18 4.04
86 Phosphoglycerate kinase 44.590 6.37 8 2.33
65 Malate dehydrogenase 35.544 8.93 4 2.02
149 Putative stress response protein 59.391 5.93 15 3.98
26 Nucleotide transport and metabolism hydrolase 25.680 5.96 15 3.07
153 Aldehyde dehydrogenase 27.079 5.77 5 3.89
176 Heat shock protein 70 69.806 5.06 13 2.98
72 Glyceraldehyde 3-phosphate dehydrogenase 35.871 6.46 2 2.12
136, 47 Methionine aminopeptidase 44.307 6.48 4 1.92
*Expression ratio of fluconazole-resistant (R) over fluconazole-susceptible (S) strains. The minus sign (-) indicatesthe decreased protein expression of
fluconazole-resistant strains in comparison with fluconazole-susceptible strains.
LC-MS/MS: liquid chromatography-tandem mass spectrometry.
Fluconazole-resistant Candida glabrata 77response protein, aldehyde dehydrogenase, and heat
shock protein, among others, were increased, whereas the
expression levels of phosphoglycerate kinase, malate
dehydrogenase, and UgP1 protein were decreased. Of
note, the expression levels of stress response protein and
aldehyde dehydrogenase were 3.8-fold higher in the
fluconazole-resistant strain compared with the
fluconazole-susceptible strain (Table 1). In the cellular
protein fraction, several proteins showed decreased
expression, but only four were upregulated in the
fluconazole-resistant strains: fructose bisphosphate
aldolase, phosphoglycerate kinase, and another unnamedTable 2. Differentially expressed cellular proteins, as identi











286 GroEL-like type I
chaperonin
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287, 290, 217, 284,
248
Heat shock protein70 66




282, 250 Putative pyruvate
decarboxylase
61











*Expression ratio of fluconazole-resistant (R) over fluconazole-susceptible (S
fluconazole-resistant strains in comparison with fluconazole-susceptible strains.
LC-MS/MS: liquid chromatography-tandem mass spectrometry.protein. Among the identified proteins, heat shock protein
70 was found in five protein spots and hexokinase was
identified in three spots (Table 2).4. Discussion
C glabrata has an intrinsic tendency to resist the
antifungal agent, fluconazole. The exact mechanisms
underlying fluconazole resistance are not well known.
Recently, however, a proteomic analysis study revealed







.726 5.59 10 1.90
.322 5.49 4 1.90
.590 6.37 16 1.71
.351 5.14 5 2.50
.355 5.32 5 2.31
.772 5.23 32 2.30
.032 5.01 4 2.15
.531 5.43 6 2.09
.060 6.08 6 2.03
.917 7.7 7 1.95
.169 5.96 1 1.83
.167 8.46 5 1.75
.532 4.84 83 1.66
) strains. The minus sign (-) indicates decreased protein expression of
78 J.I. Yoo, et alresistance [16]. In this study, we determined that cellular
and membrane proteins are differentially expressed
between fluconazole-susceptible and -resistant strains. A
total of 31 proteins were identified by LC-MS/MS that are
involved in glycolysis, carbohydrate transport, energy
transfer, and other metabolic pathways. Heat shock
protein was one of the most frequently identified cellular
proteins. Fluconazole-resistant strains exhibited several
downregulated proteins in the cellular fraction, while
those in the membrane fraction were mostly upregulated.
The overall fold change was narrow in the cellular
proteins (1.6e2.5-fold), but was larger in the membrane
proteins (1.9e4.4-fold), indicating that membrane
proteins responded more severely to fluconazole-induced
stress than cellular proteins. The expression of heat shock
protein in the cellular fraction was decreased 2.31-fold; in
the membrane fraction, heat shock protein 70 was
increased by 2.98-fold and one stress response proteinwas
increased by 3.98-fold. Usually, the expression of heat
shock protein is not only regulated by temperature but also
a range of noxious stimuli, including stress in general.
Stress response protein has been previously associated
with C glabrata biofilm formation. The association
between fluconazole resistance and heat shock protein/
stress response protein expression should be further
investigated in future studies.Acknowledgments
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